| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Monitoring of HIV viral loads, CD4 cell counts, and clinical assessments versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER): a randomised non-inferiority trial.
|
Lancet Infect Dis
|
2011
|
2.82
|
|
2
|
Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110/ESTHER): a cost-effectiveness analysis.
|
Lancet Infect Dis
|
2013
|
2.51
|
|
3
|
Time patterns of adherence and long-term virological response to non-nucleoside reverse transcriptase inhibitor regimens in the Stratall ANRS 12110/ESTHER trial in Cameroon.
|
Antivir Ther
|
2013
|
1.68
|
|
4
|
Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy.
|
Antivir Ther
|
2005
|
1.40
|
|
5
|
Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe.
|
Eur J Cancer
|
2007
|
1.40
|
|
6
|
Determinants of unplanned antiretroviral treatment interruptions among people living with HIV in Yaoundé, Cameroon (EVAL survey, ANRS 12-116).
|
Trop Med Int Health
|
2008
|
1.26
|
|
7
|
Self-reported fatigue and depressive symptoms as main indicators of the quality of life (QOL) of patients living with HIV and Hepatitis C: implications for clinical management and future research.
|
HIV Clin Trials
|
2007
|
1.14
|
|
8
|
Performance of HIV care decentralization from the patient's perspective: health-related quality of life and perceived quality of services in Cameroon.
|
Health Policy Plan
|
2011
|
1.12
|
|
9
|
Prevalence of unsafe sex with one's steady partner either HIV-negative or of unknown HIV status and associated determinants in Cameroon (EVAL ANRS12-116 survey).
|
Sex Transm Infect
|
2009
|
1.08
|
|
10
|
Expanding access to non-medicalized community-based rapid testing to men who have sex with men: an urgent HIV prevention intervention (the ANRS-DRAG study).
|
PLoS One
|
2013
|
0.99
|
|
11
|
The effect of depressive symptoms at ART initiation on HIV clinical progression and mortality: implications in clinical practice.
|
Antivir Ther
|
2007
|
0.98
|
|
12
|
Delayed first consultation after diagnosis of HIV infection in Cameroon.
|
AIDS
|
2009
|
0.98
|
|
13
|
Drug injection cessation among HIV-infected injecting drug users.
|
Addict Behav
|
2004
|
0.98
|
|
14
|
Acceptability of an "on-demand" pre-exposure HIV prophylaxis trial among men who have sex with men living in France.
|
AIDS Care
|
2011
|
0.96
|
|
15
|
Higher risk of unsafe sex and impaired quality of life among patients not receiving antiretroviral therapy in Cameroon: results from the EVAL survey (ANRS 12-116).
|
AIDS
|
2010
|
0.95
|
|
16
|
Empowering HIV testing as a prevention tool: targeting interventions for high-risk men who have sex with men.
|
AIDS Care
|
2012
|
0.92
|
|
17
|
Individual and structural factors associated with HIV status disclosure to main partner in Cameroon: ANRS 12-116 EVAL survey, 2006-2007.
|
J Acquir Immune Defic Syndr
|
2011
|
0.91
|
|
18
|
The role of adherence in virological suppression in patients receiving anti-HBV analogues.
|
Antivir Ther
|
2011
|
0.88
|
|
19
|
Task shifting HIV care in rural district hospitals in Cameroon: evidence of comparable antiretroviral treatment-related outcomes between nurses and physicians in the Stratall ANRS/ESTHER trial.
|
J Acquir Immune Defic Syndr
|
2013
|
0.87
|
|
20
|
Assessing adherence to antiretroviral therapy in randomized HIV clinical trials: a review of currently used methods.
|
Expert Rev Anti Infect Ther
|
2013
|
0.87
|
|
21
|
Desire for a child among HIV-infected women receiving antiretroviral therapy in Cameroon: results from the national survey EVAL (ANRS 12-116).
|
AIDS Care
|
2010
|
0.86
|
|
22
|
Engaging HIV-HCV co-infected patients in HCV treatment: the roles played by the prescribing physician and patients' beliefs (ANRS CO13 HEPAVIH cohort, France).
|
BMC Health Serv Res
|
2012
|
0.85
|
|
23
|
Psychosocial correlates of inconsistent condom use among HIV-infected patients enrolled in a structured ART interruptions trial in Côte d'Ivoire: results from the TRIVACAN trial (ANRS 1269).
|
Trop Med Int Health
|
2010
|
0.85
|
|
24
|
Adding HCV treatment to HIV treatment in HIV-HCV coinfected patients: the impact on the different dimensions of fatigue and self-reported side effects.
|
J Pain Symptom Manage
|
2007
|
0.84
|
|
25
|
Physicians' and patients' adherence to antiretroviral prophylaxis after sexual exposure to HIV: results from South-Eastern France.
|
AIDS Care
|
2008
|
0.84
|
|
26
|
Longevity of popes and artists between the 13th and the 19th century.
|
Int J Epidemiol
|
2005
|
0.82
|
|
27
|
Health-related quality of life of people living with HIV followed up in hospitals in France: comparing trends and correlates between 2003 and 2011 (ANRS-VESPA and VESPA2 national surveys).
|
AIDS Care
|
2014
|
0.82
|
|
28
|
Susceptibility to transmitting HIV in patients initiating antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER Trial).
|
PLoS One
|
2013
|
0.81
|
|
29
|
Adherence as a predictor of sexual behaviors in people living with HIV/AIDS during the first year of antiretroviral therapy in rural Cameroon: data from Stratall ANRS 12110/ESTHER trial.
|
PLoS One
|
2012
|
0.81
|
|
30
|
Incidence, medical and socio-behavioural predictors of psychiatric events in an 11-year follow-up of HIV-infected patients on antiretroviral therapy.
|
Antivir Ther
|
2012
|
0.81
|
|
31
|
20-years of population-based cancer registration in hepatitis B and liver cancer prevention in the Gambia, West Africa.
|
PLoS One
|
2013
|
0.81
|
|
32
|
Proximity to HIV is associated with a high rate of HIV testing among men who have sex with men living in Douala, Cameroon.
|
AIDS Care
|
2012
|
0.80
|
|
33
|
Self-reported alcohol abuse in HIV-HCV co-infected patients: a better predictor of HIV virological rebound than physician's perceptions (HEPAVIH ARNS CO13 cohort).
|
Addiction
|
2013
|
0.80
|
|
34
|
Prediction of HIV drug resistance based on virologic, immunologic, clinical, and/or adherence criteria in the Stratall ANRS 12110/ESTHER trial in Cameroon.
|
Clin Infect Dis
|
2013
|
0.79
|
|
35
|
Impact of HAART-related side effects on unsafe sexual behaviours in HIV-infected injecting drug users: 7-year follow up.
|
AIDS
|
2004
|
0.79
|
|
36
|
Decentralization of access to antiretroviral therapy in Cameroon: correlates of HIV physicians' knowledge in HIV care.
|
Antivir Ther
|
2011
|
0.79
|
|
37
|
Depressive symptoms and exposure to efavirenz in West African HIV-infected adults.
|
HIV Clin Trials
|
2009
|
0.78
|
|
38
|
Impaired anger control as an underappreciated side effect of treatments for chronic HCV infection in HIV-HCV coinfected patients.
|
J Clin Gastroenterol
|
2008
|
0.77
|
|
39
|
Twelve-year mortality in HIV-infected patients receiving antiretroviral therapy: the role of social vulnerability. The ANRS CO8 APROCO-COPILOTE cohort.
|
Antivir Ther
|
2015
|
0.77
|
|
40
|
Determinants of benzodiazepine use in a representative population of HIV-infected individuals: the role of HIV status disclosure (ANRS-EN12-VESPA study).
|
AIDS Care
|
2011
|
0.77
|
|
41
|
Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users.
|
Addiction
|
2011
|
0.77
|
|
42
|
Using patient-reported outcomes to improve the management of co-infection with HIV and HCV: the ANRS CO13 HEPAVIH cohort.
|
Expert Rev Gastroenterol Hepatol
|
2014
|
0.77
|
|
43
|
Impact of HCV treatment and depressive symptoms on adherence to HAART among HIV-HCV-coinfected patients: results from the ANRS-CO13-HEPAVIH cohort.
|
Antivir Ther
|
2013
|
0.76
|
|
44
|
Time to combine intervention with prevention in countries where HIV is also driven by hazardous drinking: The journal publishes both invited and unsolicited letters.
|
Addiction
|
2012
|
0.76
|
|
45
|
Changes in sexual activity and risk behaviors among PLWHA initiating ART in rural district hospitals in Cameroon -- data from the STRATALL ANRS 12110/ESTHER trial.
|
AIDS Care
|
2013
|
0.76
|
|
46
|
Reconceptualizing research on HIV treatment outcomes among criminalized groups.
|
J Acquir Immune Defic Syndr
|
2012
|
0.75
|
|
47
|
Statistical fallibility and the longevity of popes: William Farr meets Wilhelm Lexis.
|
Int J Epidemiol
|
2006
|
0.75
|
|
48
|
Spontaneous and post-treatment HCV clearance: relationships with health-related quality of life in HIV infection (ANRS-VESPA2 study).
|
Expert Rev Gastroenterol Hepatol
|
2015
|
0.75
|
|
49
|
Short article: Fatigue in the long term after HCV treatment in HIV-HCV-coinfected patients: functional limitations persist despite viral clearance in patients exposed to peg-interferon/ribavirin-containing regimens (ANRS CO13-HEPAVIH cohort).
|
Eur J Gastroenterol Hepatol
|
2016
|
0.75
|
|
50
|
Choice of therapeutic strategies in the context of HIV infection: key role of patient-reported outcomes.
|
Expert Rev Anti Infect Ther
|
2012
|
0.75
|
|
51
|
No condoms for prisoners: accumulating risks of HIV, STI but also hepatitis transmission.
|
Sex Transm Infect
|
2013
|
0.75
|
|
52
|
Quality of life assessment in HIV clinical research in resource-limited settings: better late than never.
|
Trop Med Int Health
|
2010
|
0.75
|